Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 63%
Hold 13%
Sell 0%
Strong Sell 0%

Bulls say

CareTrust REIT Inc. has significantly expanded its structured finance portfolio from $15 million in early 2022 to $871 million as of now, which has strategically enhanced operator relationships and diversified portfolio yield. This asset class has shown robust performance, with shopping healthcare-related public REITs averaging 22% same-store NOI growth over the past two years, and there remains a positive supply/demand dynamic expected to continue for at least five more years. Additionally, with management nearing the completion of its portfolio optimization plan and tenant credit concerns stabilizing, CareTrust REIT is well-positioned for incremental growth, further supported by an improved competitive landscape for capital deployment.

Bears say

The financial outlook for CareTrust REIT appears negative due to a combination of lower growth projections and potential declines in cash collections, which are expected to decrease by approximately 5%. Moreover, increasing competition may lead to rising property prices, thereby adversely affecting profitability, while proposed legislative changes, such as the CA 525 bill, could further pressure operators' profitability and impact the rent received by CareTrust. Additionally, uncertainty in capital markets could hinder investment activity and negatively influence the valuation of the company's assets, suggesting significant risks to revenue stability and future growth.

CareTrust REIT (CTRE) has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 63% recommend Buy, 13% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 8 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.